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Introduction
Mitral valve incompetence is characterised by ‘ballooning’ or prolapse 
of the mitral valve, followed by the eventual retrograde flow of blood 
into the left atrium during ventricular systole. Most commonly caused 
by degenerative, rheumatic, ischaemic or infectious pathological 
processes, 2,182 Australians were diagnosed with mitral valve 
insufficiency and 370 with mitral valve prolapse in 2004/05. [1,2] 
Congenital deformities, endocardial lesions, cardiomyopathies and 
connective tissue disorders are less frequent triggers of disordered 
mitral valve function. [1]
Degenerative changes are the most common cause of mitral 
insufficiency, resulting in a range of conditions including mitral valve 
prolapse, insufficiency (‘floppy valve syndrome‘) and, in a minority of 
patients, severe mitral regurgitation (due to rupture of the chordae 
tendineae, dilatation of the mitral valve annulus or a combination of 
both complications) (Figure 1). 
Chronic rheumatic heart disease is a common cause of mitral valve 
disorders in Aboriginal and Torres Strait Islander populations, with 
a prevalence of 16.6 per 1,000 population in the Top End of the 
Northern Territory and 12.5 per 1,000 in Central Australia, compared 
with respective figures of 1.7 per 1,000 and 0.6 per 1,000 amongst 
other Australians. [3] Although more commonly associated with mitral 
stenosis, rheumatic heart disease may result in a combined stenosis 
and insufficiency, or occasionally, an isolated rheumatic insufficiency. 
[1]
Whatever the cause, mitral valve insufficiency ultimately results in 
retrograde flow of blood from the left ventricle (LV) to the left atrium 
during left ventricular systole, leading to a volume overload of the left 
atrial chamber. The response of the myocardium varies depending on 
the pathophysiological syndrome present when regurgitation occurs. 
In acute severe mitral regurgitation, the sudden volume overload 
of the left atrium and left ventricle precludes the development of 
compensatory eccentric hypertrophy (due to the rapid nature of the 
condition), with a consequent simultaneous reduction of forward 
cardiac output and pulmonary congestion. 
The patient presents with severe symptoms including dyspnoea, a 
systolic murmur (although it may not be pansystolic and occasionally 
may be absent) and an S3 heart sound or early diastolic rumble. [4] 
In comparison, the myocardium of patients experiencing a chronic, 
mild mitral regurgitation will undergo eccentric hypertrophy, resulting 
in a compensatory increase in end-diastolic volume that results in an 
increased stroke volume and restoration of cardiac output. [4] 
Eventually, these patients will experience left ventricular 
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decompensation, with a considerably reduced systolic ejection 
capability. This results in a reduced forward output, often with an 
ejection fraction in the lower normal range (EF 0.50-0.60), [4] and 
consequent volume overload of the left atrium with left atrial dilatation 
and potentially the development of atrial fibrillation. LV dysfunction 
and left atrial volume overload also generate a retrograde pressure 
gradient through the pulmonary circulation, resulting in pulmonary 
congestion, and respiratory signs of heart failure. Physical examination 
of patients with chronic asymptomatic mitral regurgitation frequently 
demonstrates displacement of the apex beat due to eccentric 
hypertrophy and possibly a palpable heave. An S3 heart sound is usually 
present and there may be a pansystolic murmur. Findings indicative 
of the development of pulmonary hypertension in these patients are 
suggestive of an advanced disease state and worsening prognosis. [4]
Diagnosis of mitral valve insufficiency is based on symptoms, physical 
findings and two-dimensional and Doppler echocardiography indicating 
a leaflet thickness of >5mm and/or leaflet prolapsed >2mm. [4]
Figure 1. Long-shafted instruments in use during mitral valve repair.
Minimally invasive mitral valve repair (MIMVR) is a relatively new 
alternative to median sternotomy for valvular heart surgery, and 
has become increasingly appealing due to its improved cosmetic 
results and more rapid recovery time. Patients suffering mitral 
valve disease are increasingly turning to their medical practitioners 
for advice regarding this procedure. It is the aim of this article to 
provide a review of MIMVR to allow students and doctors to better 
understand this recent development in cardiac surgical therapy. 
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Figure 2. Femoro-femoral bypass cannulae in situ.
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with the Da Vinci Robotic Surgical System, which may be used to 
perform minimally invasive mitral valve repair. The technique outlined 
below does not use the Da Vinci system, instead being performed 
directly by the surgeon utilising specific long-shafted instruments 
(Figure 2).
Pre-operative assessment of vascular status is important as use of 
the EndoCPB© system may be contraindicated in some patients with 
peripheral vascular disease. [6] Physical examination and Doppler 
sonography remain the mainstay of pre-operative vascular assessment.
Intubation is performed by a qualified cardiothoracic anaesthetist 
with a double-lumen endotracheal tube. The patient is placed in the 
dorsal decubitus position and transoesophageal echocardiography is 
commenced. Femoral cutdown is performed and access is gained to 
the jugular vein, allowing placement of cannulae for femoro-femoral 
cardiopulmonary bypass (Figure 3) and endocoronary sinus catheter 
placement respectively. [5,7,8]
Once cardiopulmonary bypass cannulae are in place, a 4-5cm incision 
is made in the skin of the right inframammary groove, and a port is 
created in the fourth intercostal space. Soft tissue retractors are then 
used to retract the soft tissues, providing access to the thoracic cavity 
(Figure 4). [5-9] A second port is created in the third intercostal space 
to allow access for the thoracoscope.
The ascending aorta is clamped and retrograde cardioplegia delivered 
to the heart. Aortic clamping is obtained through the use of either a 
standard aortic cross-clamp at the root of the aorta or an endoaortic 
balloon clamp that also allows monitoring of aortic root pressure. 
Minimally invasive mitral valve surgery 
Currently, there are three different operations performed for mitral 
regurgitation: repair, replacement with preservation of the mitral 
structures, or replacement with removal of the mitral structures. 
The indications of mitral valve surgery are: 
• Symptomatic acute severe mitral regurgitation.
• Chronic severe mitral regurgitation with at least one of the 
following:  
Mitral valve repair may be considered in:
• Severe chronic mitral regurgitation, requiring surgery.
• Asymptomatic chronic severe mitral regurgitation with presernved 
LV function (EF >o.60 & end-systolic dimension <40mm).
• Chronic severe secondary mitral regurgitation due to severe LV 
dysfunction, with persistent NYHA class III-IV symptoms despite 
optimal heart failure therapy, including bi-ventricular pacing.
The midline sternotomy remains the most common incision in 
cardiothoracic surgery, offering excellent access to all intrathoracic 
structures. It currently remains the standard approach for aortic and 
mitral valve surgery. [5]
Minimally invasive mitral valve surgery, specifically port-access mitral 
valve surgery, is a video-assisted endoscopic technique allowing mitral 
valve replacement or repair (valvuloplasty and/or annuloplasty) 
via a series of intercostal ports, thus removing the need for median 
sternotomy. [5-9]
The minimally invasive technique described is based on the use of the 
EndoCPB© endovascular cardiopulmonary bypass system, created by 




More rapid return to normal activity
Reduced pain
Reduced incidence of sepsis and wound infection
Reduced occurrence of new-onset atrial fibrillation
Shorter hospital stay




Table 1. The benefits of minimally invasive mitral valve repair, as compared to 
conventional surgical approaches.
Figure 3. Surgeon’s view through left-sided atriotomy showing the mitral valve 
in the centre of the picture.
Figure 3. Preparation of Gore-Tex sutures measured against long-arm callipers.
- NYHA functional class II, III, IV symptoms in the absence of 
severe LV dysfunction (severe LV dysfunction defined as EF 
<0.30) and/or end-systolic dimension >55mm; or
- Asymptomatic with mild to moderate LV dysfunction, EF 0.30 
– 0.60 and/or end-systolic dimension >/= 40mm; or
- Asymptomatic chronic severe mitral regurgitation with 
preserved LV function and new; or
- Asymptomatic chronic severe mitral regurgitation with 
preserved LV function and pulmonary hypertension 
(Pulmonary artery systolic pressure >50mmHg at rest or 
>60mmHg with exercise).
- Chronic severe mitral regurgitation due to a primary 
abnormality of mitral apparatus and NYHA classification III-
IV symptoms with severe LV dysfunction (EF <0.30 and/or 
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Surgical access to the mitral valve is gained via a left atriotomy, 
allowing the surgeon to look down through the lumen of the valve 
into the left ventricle (Figure 5). The damage to the valve can then 
be assessed visually, and repaired through valvuloplasty, chordal 
repair or annuloplasty. Ruptured chordae tendineae can be excised 
and replaced by Dacron suturing measured against the distance 
from valve leaflet to papillary muscle by long-arm suture calipers. If 
annuloplasty is required, the valve size is measured using a valve sizer, 
and an annuloplasty ring lowered to the atrial surface of the valve. 
The atriotomy is then closed, the patient placed in the Trendelenburg 
and lateral decubitus positions, and de-airing commenced. Heartbeat 
is resumed, and the patient is weaned from cardiopulmonary bypass 
prior to transfer to the intensive care unit. [5-9]
Discussion
Minimally invasive mitral valve repair (MIMVR) is an evolving procedure 
that, although developed in 1996, [5] is now coming to play a large part 
in the surgical management of valvular heart disease. 
While no thorough analyses have been completed by government 
or clinical authorities (such as the UK National Institute of Clinical 
Excellence or the Australian Safety and Efficacy Register of New 
Interventional Procedures - Surgical), original research suggests that 
MIMVR is a viable and safe alternative to standard median sternotomy 
for mitral valve surgery, conferring a multitude of benefits to the 
patient (Table 1). [5-16]
Yet despite its multiple benefits, reduced costs and improved cosmetics, 
MIMVR has its own unique set of potential complications. By 1999 there 
had been 25 reported cases of retrograde aortic dissection worldwide 
associated with surgery. Potential exists for cerebrovascular accident 
(occurring in 0.6% of cases in the port-access international registry). 
The endoaortic balloon may migrate to the aortic valve, perforate, or 
be captured during suturing. Femoral arterial cannulation may prove 
to be impossible in some patients necessitating a change of procedure 
to median sternotomy. Other potential complications include kinking 
or obstruction of the venous cannulae inadvertent placement of 
the venous cannula in the superior vena cava and perforation of the 
coronary sinus, right atrium by a guidewire or of the left atrium via an 
atrial septal defect. [5,14] 
Overall however, MIMVR is held to be a viable alternative to median 
sternotomy, with a comparable level of clinical safety. [5-16] Data 
from one study suggests that MIMVR is associated with a lower 
morbidity and shorter hospital stay in elderly patients when compared 
to standard mitral valve replacement via median sternotomy. [13] 
Whilst one prospective, randomised study suggested that there were 
no significant advantages of minimally invasive port access technique 
over median sternotomy, and that MIMVR was associated with a 
longer operating time and more intraoperative procedure-related 
problems, the authors conceded that their study was limited by their 
own experience with minimally invasive techniques. Further, the small 
sample sizes of their groups restricted their ability to detect statistically 
significant differences in clinical, biochemical and neuropsychological 
variables. [15]
Conclusion
MIMVR is a safe, viable alternative to median sternotomy in patients 
with adequate peripheral vasculature, and offers significant advantages 
in terms of morbidity, cost, patient satisfaction and cosmetics when 





Figure 5. Insertion of annuloplasty ring.
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